These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 27357661)
1. Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts. Guaitoli G; Raimondi F; Gilsbach BK; Gómez-Llorente Y; Deyaert E; Renzi F; Li X; Schaffner A; Jagtap PK; Boldt K; von Zweydorf F; Gotthardt K; Lorimer DD; Yue Z; Burgin A; Janjic N; Sattler M; Versées W; Ueffing M; Ubarretxena-Belandia I; Kortholt A; Gloeckner CJ Proc Natl Acad Sci U S A; 2016 Jul; 113(30):E4357-66. PubMed ID: 27357661 [TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the WD40 domain dimer of LRRK2. Zhang P; Fan Y; Ru H; Wang L; Magupalli VG; Taylor SS; Alessi DR; Wu H Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1579-1584. PubMed ID: 30635421 [TBL] [Abstract][Full Text] [Related]
4. Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain. Li X; Qi Z; Ni D; Lu S; Chen L; Chen X Molecules; 2021 Sep; 26(18):. PubMed ID: 34577121 [TBL] [Abstract][Full Text] [Related]
5. First model of dimeric LRRK2: the challenge of unrevealing the structure of a multidomain Parkinson's-associated protein. Guaitoli G; Gilsbach BK; Raimondi F; Gloeckner CJ Biochem Soc Trans; 2016 Dec; 44(6):1635-1641. PubMed ID: 27913672 [TBL] [Abstract][Full Text] [Related]
6. A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2. Dederer V; Sanz Murillo M; Karasmanis EP; Hatch KS; Chatterjee D; Preuss F; Abdul Azeez KR; Nguyen LV; Galicia C; Dreier B; Plückthun A; Versees W; Mathea S; Leschziner AE; Reck-Peterson SL; Knapp S J Biol Chem; 2024 Jul; 300(7):107469. PubMed ID: 38876305 [TBL] [Abstract][Full Text] [Related]
7. Insights into the Influence of Specific Splicing Events on the Structural Organization of Vlachakis D; Labrou NE; Iliopoulos C; Hardy J; Lewis PA; Rideout H; Trabzuni D Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223621 [TBL] [Abstract][Full Text] [Related]
8. Structural analysis of the full-length human LRRK2. Myasnikov A; Zhu H; Hixson P; Xie B; Yu K; Pitre A; Peng J; Sun J Cell; 2021 Jun; 184(13):3519-3527.e10. PubMed ID: 34107286 [TBL] [Abstract][Full Text] [Related]
9. Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2. Vancraenenbroeck R; Lobbestael E; Weeks SD; Strelkov SV; Baekelandt V; Taymans JM; De Maeyer M Biochim Biophys Acta; 2012 Mar; 1824(3):450-60. PubMed ID: 22251894 [TBL] [Abstract][Full Text] [Related]
10. From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease. Herbst S; Lewis PA Biochem J; 2021 Jul; 478(14):2945-2951. PubMed ID: 34328508 [TBL] [Abstract][Full Text] [Related]
11. Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity. Nguyen AP; Moore DJ Adv Neurobiol; 2017; 14():71-88. PubMed ID: 28353279 [TBL] [Abstract][Full Text] [Related]